BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 32392110)

  • 1. Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
    Puranik N; Yadav D; Yadav SK; Chavda VK; Jin JO
    Curr Protein Pept Sci; 2020; 21(12):1174-1183. PubMed ID: 32392110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Contemporary Neuroproteomic Techniques in Unravelling Neurological Disorders.
    Khurana M; Rahman SO; Najmi AK; Pottoo FH; Akhtar MS
    Curr Protein Pept Sci; 2020; 21(12):1146-1163. PubMed ID: 33148155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases.
    Li K; Chen Z; Zhang Y; Yang X
    Curr Protein Pept Sci; 2020; 21(12):1202-1217. PubMed ID: 33143625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases.
    Bandookwala M; Sengupta P
    Int J Neurosci; 2020 Oct; 130(10):1047-1062. PubMed ID: 31914343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging biomarkers of neurodegenerative diseases and dementia.
    Risacher SL; Saykin AJ
    Semin Neurol; 2013 Sep; 33(4):386-416. PubMed ID: 24234359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
    Marrero-Winkens C; Sankaran C; Schätzl HM
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
    Di Domenico F; Tramutola A; Butterfield DA
    Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's and Parkinson's diseases: an environmental proteomic point of view.
    Demartini DR; Schilling LP; da Costa JC; Carlini CR
    J Proteomics; 2014 Jun; 104():24-36. PubMed ID: 24751585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroproteomic profiling of human body fluids.
    Häggmark A; Schwenk JM; Nilsson P
    Proteomics Clin Appl; 2016 Apr; 10(4):485-502. PubMed ID: 26286680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Analysis of Huntington's Disease.
    Kumar S; Singh P; Sharma S; Ali J; Baboota S; Pottoo FH
    Curr Protein Pept Sci; 2020; 21(12):1218-1222. PubMed ID: 33023443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the protein-RNA recognition code in neurodegeneration.
    Nahalka J
    Cell Mol Life Sci; 2019 Jun; 76(11):2043-2058. PubMed ID: 30980111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Looking backward to move forward: early detection of neurodegenerative disorders.
    DeKosky ST; Marek K
    Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biomarkers of neurodegeneration.
    Höglund K; Salter H
    Expert Rev Mol Diagn; 2013 Nov; 13(8):845-61. PubMed ID: 24151849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroproteomics tools in clinical practice.
    Shevchenko G; Konzer A; Musunuri S; Bergquist J
    Biochim Biophys Acta; 2015 Jul; 1854(7):705-17. PubMed ID: 25680928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Analysis of the Human Olfactory Bulb.
    Dammalli M; Dey G; Madugundu AK; Kumar M; Rodrigues B; Gowda H; Siddaiah BG; Mahadevan A; Shankar SK; Prasad TSK
    OMICS; 2017 Aug; 21(8):440-453. PubMed ID: 28816642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of proteomics to neurological diseases].
    Brea D; Cristobo I; Sobrino T; Rodríguez-González R; Mosquera E; Moldes O; Castillo J
    Neurologia; 2007 Apr; 22(3):170-9. PubMed ID: 17364255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy.
    Dupiereux I; Zorzi W; Quadrio I; Perret-Liaudet A; Kovacs GG; Heinen E; Elmoualij B
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):2-11. PubMed ID: 20021333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.